African-made antiretroviral generics are transforming HIV treatment access, with the first WHO-prequalified TLD regimen produced in Kenya and delivered to Mozambique in 2025. Local production is reducing dependency on imports, cutting costs, and building long-term health sovereignty.
Nov 24 2025
A clear comparison of Azee DT (azithromycin) with five common antibiotic alternatives, covering uses, side‑effects, resistance, costs and when to choose each option.
Oct 25 2025
A practical guide comparing oseltamivir with other flu antivirals, covering mechanisms, efficacy, resistance, cost, and prescribing tips.
Oct 24 2025
Explore why a cross‑disciplinary approach-linking virology, veterinary science, data analytics, and public health-is essential to combat reemerging influenza and prevent future outbreaks.
Oct 21 2025